IBDEI1L9 ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,28196,1,4,0)
 ;;=4^681.10
 ;;^UTILITY(U,$J,358.3,28196,1,5,0)
 ;;=5^Cellulitis Of Toe
 ;;^UTILITY(U,$J,358.3,28196,2)
 ;;=^271885
 ;;^UTILITY(U,$J,358.3,28197,0)
 ;;=682.2^^162^1793^14
 ;;^UTILITY(U,$J,358.3,28197,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28197,1,4,0)
 ;;=4^682.2
 ;;^UTILITY(U,$J,358.3,28197,1,5,0)
 ;;=5^Cellulitis Of Trunk
 ;;^UTILITY(U,$J,358.3,28197,2)
 ;;=^271890
 ;;^UTILITY(U,$J,358.3,28198,0)
 ;;=691.8^^162^1793^18
 ;;^UTILITY(U,$J,358.3,28198,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28198,1,4,0)
 ;;=4^691.8
 ;;^UTILITY(U,$J,358.3,28198,1,5,0)
 ;;=5^Dermatitis, Atopic
 ;;^UTILITY(U,$J,358.3,28198,2)
 ;;=^87342
 ;;^UTILITY(U,$J,358.3,28199,0)
 ;;=692.9^^162^1793^28
 ;;^UTILITY(U,$J,358.3,28199,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28199,1,4,0)
 ;;=4^692.9
 ;;^UTILITY(U,$J,358.3,28199,1,5,0)
 ;;=5^Eczema, Allergic
 ;;^UTILITY(U,$J,358.3,28199,2)
 ;;=^27800
 ;;^UTILITY(U,$J,358.3,28200,0)
 ;;=693.0^^162^1793^24
 ;;^UTILITY(U,$J,358.3,28200,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28200,1,4,0)
 ;;=4^693.0
 ;;^UTILITY(U,$J,358.3,28200,1,5,0)
 ;;=5^Drug Dermatitis NOS
 ;;^UTILITY(U,$J,358.3,28200,2)
 ;;=^33042
 ;;^UTILITY(U,$J,358.3,28201,0)
 ;;=459.81^^162^1793^19
 ;;^UTILITY(U,$J,358.3,28201,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28201,1,4,0)
 ;;=4^459.81
 ;;^UTILITY(U,$J,358.3,28201,1,5,0)
 ;;=5^Dermatitis, Stasis
 ;;^UTILITY(U,$J,358.3,28201,2)
 ;;=^125826
 ;;^UTILITY(U,$J,358.3,28202,0)
 ;;=110.0^^162^1793^62
 ;;^UTILITY(U,$J,358.3,28202,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28202,1,4,0)
 ;;=4^110.0
 ;;^UTILITY(U,$J,358.3,28202,1,5,0)
 ;;=5^Tinea Versicolor
 ;;^UTILITY(U,$J,358.3,28202,2)
 ;;=^33176
 ;;^UTILITY(U,$J,358.3,28203,0)
 ;;=110.5^^162^1793^21
 ;;^UTILITY(U,$J,358.3,28203,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28203,1,4,0)
 ;;=4^110.5
 ;;^UTILITY(U,$J,358.3,28203,1,5,0)
 ;;=5^Dermatophytosis Of Body
 ;;^UTILITY(U,$J,358.3,28203,2)
 ;;=^33179
 ;;^UTILITY(U,$J,358.3,28204,0)
 ;;=110.6^^162^1793^23
 ;;^UTILITY(U,$J,358.3,28204,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28204,1,4,0)
 ;;=4^110.6
 ;;^UTILITY(U,$J,358.3,28204,1,5,0)
 ;;=5^Dermatophytosis, Deep
 ;;^UTILITY(U,$J,358.3,28204,2)
 ;;=^266861
 ;;^UTILITY(U,$J,358.3,28205,0)
 ;;=110.4^^162^1793^22
 ;;^UTILITY(U,$J,358.3,28205,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28205,1,4,0)
 ;;=4^110.4
 ;;^UTILITY(U,$J,358.3,28205,1,5,0)
 ;;=5^Dermatophytosis Of Foot
 ;;^UTILITY(U,$J,358.3,28205,2)
 ;;=^33168
 ;;^UTILITY(U,$J,358.3,28206,0)
 ;;=110.3^^162^1793^61
 ;;^UTILITY(U,$J,358.3,28206,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28206,1,4,0)
 ;;=4^110.3
 ;;^UTILITY(U,$J,358.3,28206,1,5,0)
 ;;=5^Tinea Cruris
 ;;^UTILITY(U,$J,358.3,28206,2)
 ;;=^33171
 ;;^UTILITY(U,$J,358.3,28207,0)
 ;;=110.1^^162^1793^41
 ;;^UTILITY(U,$J,358.3,28207,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28207,1,4,0)
 ;;=4^110.1
 ;;^UTILITY(U,$J,358.3,28207,1,5,0)
 ;;=5^Onychomycosis Finger Or Toe
 ;;^UTILITY(U,$J,358.3,28207,2)
 ;;=^33173
 ;;^UTILITY(U,$J,358.3,28208,0)
 ;;=707.13^^162^1793^64
 ;;^UTILITY(U,$J,358.3,28208,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28208,1,4,0)
 ;;=4^707.13
 ;;^UTILITY(U,$J,358.3,28208,1,5,0)
 ;;=5^Ulcer Of Ankle, Non-Diabetic
 ;;^UTILITY(U,$J,358.3,28208,2)
 ;;=Ulcer of Ankle, non-diabetic^322145
 ;;^UTILITY(U,$J,358.3,28209,0)
 ;;=707.12^^162^1793^66
 ;;^UTILITY(U,$J,358.3,28209,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28209,1,4,0)
 ;;=4^707.12
 ;;^UTILITY(U,$J,358.3,28209,1,5,0)
 ;;=5^Ulcer Of Calf, Non-Diabetic
 ;;^UTILITY(U,$J,358.3,28209,2)
 ;;=Ulcer of Calf, non-diabetic^322144
 ;;
 ;;$END ROU IBDEI1L9
